Company news
Tevogen Bio Holdings Inc. news in 2025
Tevogen Bio Holdings Inc.'s news releases, calls and decks from 2025, newest first.
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
May 22, 2025
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
May 12, 2025
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
May 2, 2025
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
April 30, 2025
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
April 29, 2025
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 29, 2025
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
April 28, 2025
Tevogen Bio Announces 2025 Annual Meeting
April 25, 2025
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
April 17, 2025
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
April 15, 2025
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
April 9, 2025
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
April 8, 2025
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
April 7, 2025
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
March 26, 2025
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
March 25, 2025
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
March 10, 2025
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
March 7, 2025
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
March 3, 2025
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
February 28, 2025
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
February 21, 2025
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
February 13, 2025
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
February 13, 2025
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
February 13, 2025
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
February 12, 2025
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
February 6, 2025
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
January 27, 2025
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
January 26, 2025
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
January 23, 2025
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
January 22, 2025
Decks in 2025
- Investor Presentation (June 2025)
Investor deck · 34 slides · June 2025